astrazeneca oral glp 1 says experimental obesity pill safe in early-stage trial Elecoglipron, an oral small molecule

Competitive Landscape of Obesity GLP-1 Market The global GLP-1 and obesity drug landscape is entering a transformative phase as patent protections for semaglutide near expiry in key markets such as India and China by 2026

National Diabetes Statistics Report website [ Stierman B, Afful J, Carroll MD, Chen TC, Davy O, Fink S, Fryar CD, Gu Q, Hales CM, Hughes JP et al: National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files-Development of Files and Prevalence Estimates for Selected Health Outcomes

It acts through the growth-hormone-secretagogue/ghrelin-receptor pathway

Tap water contains minerals, chlorine, and microbesall of which are disastrous for a sensitive research compound